KHALID NOORI: Open Payments
NPI 1023106838 · NORTH BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 35 payments from 22 companies in 2025. Trend: 2023 $431 · 2024 $709 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $194 |
| Boston Scientific Corporation | 1 | $148 |
| Smith+Nephew, Inc. | 7 | $139 |
| Amgen Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Penumbra, Inc. | 1 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $49 |
| Bard Peripheral Vascular, Inc. | 1 | $34 |
Products named: Ozempic, FARAPULSE, RENASYS TOUCH, REPATHA, BREZTRI, REXULTI, Indigo System, Kerendia.
Industry payments across NY — which companies pay providers there.
